EN
Lamotrigine induced seizures in juvenile myoclonic epilepsy
Abstract
Juvenile myoclonic epilepsy (JME) is a common epileptic syndrome. Before the development of the new antiepileptic drugs (AEDs) after the 1990s, Valproate (VPA) was the first-line treatment in juvenile myoclonic epilepsy. However, the frequent adverse effects and the risk for teratogenicity have resulted in a search for alternative therapies especially in women. Lamotrigine (LTG), topiramate, and levetiracetam, have been used as monotherapy or adjunctive therapy for juvenile myoclonic epilepsy in small patient series. We report a case of a thirty one-years-old female suffered from severe aggravation in myoclonic and generalized tonic-clonic (GTC) seizures after decreasing the lose of VPA and initiating LTG.
Keywords
References
- Atakli, D., Sözüer, D., Atay, T., Baybas, S., Arpaci, B., 1998. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 7, 63-66. Auvin, S., 2008. Treatment of juvenile myoclonic epilepsy. CNS Neurosci. Ther. 14, 227-233.
- Bodenstein-Sachar, H., Gandelman-Marton, R., Ben-Zeev, B., Chapman, J., Blatt, I., 2011. Outcome of LTG treatment in juvenile myoclonic epilepsy. Acta Neurol. Scand. 124, 22-27.
- Crespel, A., Genton, P., Berramdane, M., Coubes, P., Monicard, C., Baldy-Moulinier M., Gelisse, P., 2005. LTG associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology. 65, 762-764.
- Duncan, S., 2007. Teratogenesis of sodium VPA. Curr. Opin. Neurol. 20, 175-180.
- Janszky, J., Rásonyi, G., Halász, P., Olajos, S., Perenyi, J., 2000. Disabling erratic myoclonus during lamotrigine therapy with high serum level-report of two cases. Clin. Neuropharmacol. 23, 86-89.
- Mantoan, L., Walker, M., 2011. Treatment options in juvenile myoclonic epilepsy. Curr. Treat. Options Neurol. 13, 355-370.
- Mehndiratta, M.M., Aggarwal, P., 2002. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India. Seizure. 11, 431-436.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Publication Date
July 31, 2013
Submission Date
April 15, 2013
Acceptance Date
-
Published in Issue
Year 2013 Volume: 30 Number: 2
APA
Acar, B., Dağ, E., & Türkel, Y. (2013). Lamotrigine induced seizures in juvenile myoclonic epilepsy. Deneysel Ve Klinik Tıp Dergisi, 30(2), 207-208. https://doi.org/10.5835/jecm.omu.30.02.027
AMA
1.Acar B, Dağ E, Türkel Y. Lamotrigine induced seizures in juvenile myoclonic epilepsy. J. Exp. Clin. Med. 2013;30(2):207-208. doi:10.5835/jecm.omu.30.02.027
Chicago
Acar, Betül, Ersel Dağ, and Yakup Türkel. 2013. “Lamotrigine Induced Seizures in Juvenile Myoclonic Epilepsy”. Deneysel Ve Klinik Tıp Dergisi 30 (2): 207-8. https://doi.org/10.5835/jecm.omu.30.02.027.
EndNote
Acar B, Dağ E, Türkel Y (July 1, 2013) Lamotrigine induced seizures in juvenile myoclonic epilepsy. Deneysel ve Klinik Tıp Dergisi 30 2 207–208.
IEEE
[1]B. Acar, E. Dağ, and Y. Türkel, “Lamotrigine induced seizures in juvenile myoclonic epilepsy”, J. Exp. Clin. Med., vol. 30, no. 2, pp. 207–208, July 2013, doi: 10.5835/jecm.omu.30.02.027.
ISNAD
Acar, Betül - Dağ, Ersel - Türkel, Yakup. “Lamotrigine Induced Seizures in Juvenile Myoclonic Epilepsy”. Deneysel ve Klinik Tıp Dergisi 30/2 (July 1, 2013): 207-208. https://doi.org/10.5835/jecm.omu.30.02.027.
JAMA
1.Acar B, Dağ E, Türkel Y. Lamotrigine induced seizures in juvenile myoclonic epilepsy. J. Exp. Clin. Med. 2013;30:207–208.
MLA
Acar, Betül, et al. “Lamotrigine Induced Seizures in Juvenile Myoclonic Epilepsy”. Deneysel Ve Klinik Tıp Dergisi, vol. 30, no. 2, July 2013, pp. 207-8, doi:10.5835/jecm.omu.30.02.027.
Vancouver
1.Betül Acar, Ersel Dağ, Yakup Türkel. Lamotrigine induced seizures in juvenile myoclonic epilepsy. J. Exp. Clin. Med. 2013 Jul. 1;30(2):207-8. doi:10.5835/jecm.omu.30.02.027
